Hello dear Getquin community,
today I have struck again with the following positions:
$ULVR (+0,08 %) / $UL (-0,48 %)
$BATS (+0,58 %) / $BTI (+0,81 %)
What did you buy this week or what is on your shopping list?
Looking forward to your ideas! 👀📈
Puestos
382Hello dear Getquin community,
today I have struck again with the following positions:
$ULVR (+0,08 %) / $UL (-0,48 %)
$BATS (+0,58 %) / $BTI (+0,81 %)
What did you buy this week or what is on your shopping list?
Looking forward to your ideas! 👀📈
Hello everyone,
Since I and my portfolio have recently exceeded the €50,000 mark, I wanted to take this as an opportunity to present my portfolio and my strategy to you. I look forward to your opinion, assessment, criticism and potential for improvement.
About me: I am still 29 years old and work as a team leader in an industrial company in the building materials sector. In terms of education, I feel I've been through all the stages - from a qualifying secondary school certificate to A-levels and a bachelor's degree to a master's degree. The only thing missing is a doctorate 😌
About the overall strategy: My assets are divided between my share portfolio, a condominium and a call money account. I live in your apartment myself. I wouldn't consider renting or real estate as an investment because I think the risks of having to invest money again are too high. You can also suspend the savings plan in your portfolio from time to time. So the apartment is held for as long as it is occupied and then sold when I buy a house.
About the equity strategy: I'll try to summarize this briefly
Stock selection and savings plan:
Further strategy:
At the moment I feel comfortable with the strategy and until all individual stocks etc. have been transferred to the main portfolio. It will take some time before all the individual stocks etc. are transferred to the main portfolio. In the long term, I am considering $TDIV (-1,12 %) with a 10 percent share. I will then select individual stocks in the future, but e.g. $RIO (+1,57 %) , $MUV2 (-0,42 %) or $MAIN (+1,4 %) I could well imagine.
Looking forward to your comments on this boring strategy 😌
Hello everyone!
My parents are in the process of selling my grandparents' house. It will probably fetch around €275,000. My parents will soon both be 60 years old.
They had initially considered buying another property nearby. But they have moved away again. The lack of flexibility and the time and risk involved with tenants put them off.
I also told them more about investing in the stock market. They were very open and interested, even though they said they had an unfounded fear of shares etc.
Now my question to you. What is the best way to invest the money? I think dividends would be very nice as my parents like the passive income like from a property. But it should also be very well diversified across countries and sectors.
I personally have developed 2 solutions. You can give your opinion as to whether you think the solutions are good or, of course, if you have completely different ideas.
1. the ETF solution
15% $XEOD (+0,03 %) Call money ETF. Div. 1.9%
15% $TDIV (-1,12 %) VanEck Divi Leaders. Div 3.5%
10% $TRET (-0,23 %) Global Real Estate. Div. 3.7%
7,5% $VHYL (-0,65 %) Allworld High Div Yi. Div 3.1%
7,5% $PEH (-0,42 %) FTSE RAFI EM. Div 3.9%
5% $EWG2 (+1,36 %) Gold
5% $SEDY (-0,04 %) iShares EM Dividend. Div 8.0%
5% $JEGP (-0,34 %) JPM Global Equity Inc Div 7.1%
5% $EEI (-0,51 %) WisTree Europ Equity Inc Div 6.3%
5% $IHYG (-0,15 %) High Yield Bond. Div 6.1%
5% $EXXW (-0,08 %) AsiaPac Select Div50 Div 5.5%
15% Rest German Divi Shares approx. div 2.5%
=100% with 3.7% dividend.
275k ×3,7% = 10.175€
With full taxation 27.99% = 7327€
On average per month: 610€ dividend
With 2k tax-free allowance: 657€ dividend per month
I find it very well diversified, you have overnight money, you have the USA and Europe well represented, but also 12.5% emerging markets ETF. In terms of sectors, finance will be at the forefront. Followed by real estate and energy. I think that's fine.
2. the equity solution
I have selected 34 strong dividend stocks. In the list they are roughly divided into GICS sectors.
15% $XEOD (+0,03 %) Overnight ETF. Div 1.9%
12% $EQQQ (-0,24 %) Nasdaq100 ETF. Div 0.4%
5% $EWG2 (+1,36 %) Gold
2% $O (+0,21 %) Realty Income 6.0%
2% $VICI (-0,8 %) Vici Properties 5.6%
2% $OHI (+3,89 %) Omega Healthcare 7.2%
2% $PLD (-0,06 %) Prologis 4.1%
2% $ALV (-0,92 %) Allianz 4.35%
2% $HNR1 (-0,38 %) Hannover Re 3.4%
2% $D05 (+0,8 %) DBS Group 5.5%
2% $ARCC (+0,36 %) Ares Capital 9.3
2% $6301 (+0,5 %) Komatsu. 4,2%
2% $1 (-0,49 %) CK Hutchison 4.6%
2% $AENA (+0,19 %) AENA. 4,2%
2% $LOG (-0,14 %) Logista 7.3%
1,5% $AIR (-0,76 %) Airbus 1.8%
1,5% $DHL (-2,19 %) DHL Group 4.8%
1,5% $8001 (-0,3 %) Itochu 2.8%
2% $RIO (+1,42 %) RioTinto plc 6.4%
2% $LIN (-0,05 %) Linde 1.3%
2% $ADN (-0,89 %) Acadian Timber 6.7%
3,5% $BATS (+0,58 %) BAT 7.0%
2% $KO (+0,23 %) Coca Cola 2.9
2% $HEN (-1,7 %) Henkel 3.0%
2% $KVUE (+2,14 %) Kenvue 4.1%
2% $ITX (-1,34 %) Inditex 3.6%
2% $MCD (+0,51 %) McDonalds 2.6%
2% $690D (+0,18 %) Haier Smart Home 5.6
3,5% $IBE (-0,27 %) Iberdrola. 4,1%
1,5% $AWK (-0,18 %) American Water Works 4.4%
1,5% $SHEL (+0,23 %) Shell 4.1%
1,5% $ENB (+0,32 %) Enbridge 6.5%
2% $DTE (+0,07 %) Deutsche Telekom 2.8%
2% $VZ (-0,85 %) Verizon 6.8%
2% $GSK (-2 %) GlaxoSmithKline 4.2
2% $AMGN (-1,56 %) Amgen 3.5%
2% $JNJ (-0,45 %) Johnson&Johnson 3.5%
= 100% with 3.5% dividend
275k ×3,5% = 9625€
With full taxation 27.99% = 6930€
On average per month: 577€ dividend
With 2k tax-free allowance: 624€ dividend per month
I also think this solution is cool because you can select the largest companies or strong dividend payers in the individual sectors or countries yourself. And of course you can also select shares with which you have a connection. However, I have focused on shares from the USA, England and Germany because of the withholding tax. Spain is also well represented because of my parents' ties to this country. It's also cool that the NasdaqETF also includes the Microsoft, Amazon, etc. compounders.
What do you think?
Today I topped up a little on the following titles:
What's currently on your buy list? Have you bought anything recently?
In today's video, I would like to take another look at the British American Tobacco share. The share analysis looks at the 5-year bottoming out of the highest dividend-paying shares in the consumer goods sector. I also show the current financial data and discuss the current valuation as well as the technical chart support.
How do you see the $BATS (+0,58 %) ?
Unfortunately, I missed the chance to buy BAT. The opportunity will certainly come again soon.
It's now at 42, so in my opinion buying now would be a bit pointless.
What do you think and when is a good time for you to buy?
(Edit: I'm a bit ambivalent😝 to wait or not to wait)
Velo Plus $BATS (+0,58 %) has achieved a ~12% share of the Modern Oral US market within a few months. This is expected to grow to over 50 billion dollars in the US by 2033, which corresponds to sales of 6 billion and profits of 4-5 billion, assuming the market share remains the same.
$BATS (+0,58 %) has published its half-year trading update. HY1 is somewhat boring, as the new products GLO HILO and VUSE Ultra will only be launched on the broad market in HY2.
Velo Plus is performing very strongly, while VUSE has not yet been able to stabilize due to the difficult market situation.
- Sales growthSales are slightly above the previous forecast, with expected growth of 1-2 % for the year as a whole, which supports adjusted operating profit growth of 1.5-2.5 %.
- USA: Return to sales and profit growth in the first half and full year, driven by strong performance in the tobacco business (Combustibles) and excellent results from Velo Plus.
- New categories: Low single-digit sales growth in the first half, accelerating to mid-single-digit growth for the full year, driven by innovation in key markets from mid-year. Velo shows strong global growth, while illegal vapor products in the US and Canada impact performance.
- RegionsStrong performance in AME (Africa, Middle East, Europe); APMEA (Asia Pacific) suffers from tax increases and regulatory challenges in Bangladesh and Australia.
- Cash flow and capital allocationStrong cash generation with a cash flow conversion rate of over 90%. Target is to reduce debt to 2.0-2.5x adjusted net assets/EBITDA by end 2026. Dividend policy remains progressive, share buybacks will be increased to GBP 1.1bn in 2025.
- Strategic focus: Quality growth through investment in most profitable markets, supported by partial monetization of ITC share for more financial flexibility.
- Outlook 2026: Confidence to achieve the medium-term target of 3-5% sales growth and 4-6% adjusted operating profit growth.
Product categories:
1. Combustibles: Return to growth in the USA, stable market shares despite declining industry volumes (-9 %). Strong performance of brands such as Natural American Spirit and Lucky Strike.
2. Velo (Modern Oral)Strong growth with market share gains (+550 bps in the US to 11.9% and triple-digit sales growth). Leading position in AME, especially in Scandinavia, the UK and Poland.
3. glo (Heated Tobacco)Challenging environment in Japan, but encouraging results from glo Hilo in Serbia. Planned launch in key markets from the second half of the year.
4. Vuse (Vapour): continued global leadership, but declines due to illegal products in the USA and Canada. Introduction of Vuse Ultra should improve performance in the second half of the year.
Technical forecast for 2025:
- Global tobacco industry volume: decline of approx. 2%.
- Sales growth: 1-2 % (H1 and full year, at constant exchange rates).
- New category growth: Low single digits in H1, mid single digits in full year.
- Adjusted operating profit growth: 1.5-2.5%, with an H2 weighting.
- Exchange rate effects: Transactional headwind of approx. 1.5%, translational headwind of approx. 4%.
- Net financing costs: c. GBP 1.8 bn.
- Capital expenditure: Approx. GBP 650 million.
British American Tobacco $BATS (+0,58 %) announced that sales development in the first half of the year was slightly above previous forecasts.
The Group now expects sales growth of 1-2% for the 2025 financial year, supporting adjusted operating profit growth of 1.5-2.5%. The company's previous sales growth forecast was around 1%.
Tadeu Marroco, Chief Executive, said: "2025 is a year of development and, as previously mentioned, we expect our performance to be in the second half of the year, mainly due to the launch of new category innovations in key markets from the middle of the year. In the US, I am very pleased that we expect sales and profit growth again in the first half of the year and in fiscal 2025."
$BATS (+0,58 %) has published its half-year trading update. HY1 is somewhat boring, as the new products GLO HILO and VUSE Ultra will only be launched on the broad market in HY2.
Velo Plus is performing very strongly, while VUSE has not yet been able to stabilize due to the difficult market situation.
- Sales growthSales are slightly above the previous forecast, with expected growth of 1-2 % for the year as a whole, which supports adjusted operating profit growth of 1.5-2.5 %.
- USA: Return to sales and profit growth in the first half and full year, driven by strong performance in the tobacco business (Combustibles) and excellent results from Velo Plus.
- New categories: Low single-digit sales growth in the first half, accelerating to mid-single-digit growth for the full year, driven by innovation in key markets from mid-year. Velo shows strong global growth, while illegal vapor products in the US and Canada impact performance.
- RegionsStrong performance in AME (Africa, Middle East, Europe); APMEA (Asia Pacific) suffers from tax increases and regulatory challenges in Bangladesh and Australia.
- Cash flow and capital allocationStrong cash generation with a cash flow conversion rate of over 90%. Target is to reduce debt to 2.0-2.5x adjusted net assets/EBITDA by end 2026. Dividend policy remains progressive, share buybacks will be increased to GBP 1.1bn in 2025.
- Strategic focus: Quality growth through investment in most profitable markets, supported by partial monetization of ITC share for more financial flexibility.
- Outlook 2026: Confidence to achieve the medium-term target of 3-5% sales growth and 4-6% adjusted operating profit growth.
Product categories:
1. Combustibles: Return to growth in the USA, stable market shares despite declining industry volumes (-9 %). Strong performance of brands such as Natural American Spirit and Lucky Strike.
2. Velo (Modern Oral)Strong growth with market share gains (+550 bps in the US to 11.9% and triple-digit sales growth). Leading position in AME, especially in Scandinavia, the UK and Poland.
3. glo (Heated Tobacco)Challenging environment in Japan, but encouraging results from glo Hilo in Serbia. Planned launch in key markets from the second half of the year.
4. Vuse (Vapour): continued global leadership, but declines due to illegal products in the USA and Canada. Introduction of Vuse Ultra should improve performance in the second half of the year.
Technical forecast for 2025:
- Global tobacco industry volume: decline of approx. 2%.
- Sales growth: 1-2 % (H1 and full year, at constant exchange rates).
- New category growth: Low single digits in H1, mid single digits in full year.
- Adjusted operating profit growth: 1.5-2.5%, with an H2 weighting.
- Exchange rate effects: Transactional headwind of approx. 1.5%, translational headwind of approx. 4%.
- Net financing costs: c. GBP 1.8 bn.
- Capital expenditure: Approx. GBP 650 million.
Principales creadores de la semana